Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Journal article
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
Journal article
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
Journal article
Lippert AH. et al, (2024), Immunity, 57, 256 - 270.e10
The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes
Journal article
Barreiro RAS. et al, (2023), RNA Biology, 20, 311 - 322
The current state and future of T-cell exhaustion research
Journal article
Jenkins E. et al, (2023), Oxford Open Immunology, 4
Combination CD200R/PD-1 blockade in a humanised mouse model
Journal article
Fellermeyer M. et al, (2023), Immunotherapy Advances, 3
LARP1 isoform expression in human cancer cell lines
Journal article
Schwenzer H. et al, (2021), RNA Biology, 18, 237 - 247
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate
Journal article
Jostes SV. et al, (2020), International Journal of Cancer, 146, 1592 - 1605
The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumoursin vitroandin vivo
Journal article
Jostes S. et al, (2017), Journal of Cellular and Molecular Medicine, 21, 1300 - 1314
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate
Journal article
Nettersheim D. et al, (2016), Oncotarget, 7, 47095 - 47110